The ongoing evolution in the field of genomics and biotechnology, has catalyzed innovations and advancements of gene therapies across a wide spectrum of disorders  - Genetic aberration / mutation is well known to cause several systemic and localized (organ system specific) clinical conditions resulting in severe and hard-to-treat inherited disorders. Such diseases are often treated by...

The global gene therapy market is growing rapidly; it is estimated to be worth USD 2.4 billion in 2024 and is anticipated to reach USD 16.5 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 19.25% during the forecast period.   The growth of the gene therapy market is mainly attributed to the increasing demand for tailored therapies to treat diseases that...

The global gene therapy market is estimated to grow from $2.4 billion in 2024 to $16.5 billion by 2035, representing a CAGR of 19.25% during the forecast period till 2035. It is worth highlighting that, more than 390 gene therapies have either received regulatory approval or are currently being evaluated in across various phases of clinical trials to assess the safety and effectiveness of these...

Market Overview: Global Remote Patient Monitoring Devices Market size and share is currently valued at USD 2,270.01 million in 2024 and is anticipated to generate an estimated revenue of USD 5,847.36 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 10.0% Compound Annual Growth Rate (CAGR) over the forecasted...

Stem Cell Manufacturing Market Forecast to 2035 The global Stem Cell Manufacturing Market study report provides an exclusive analysis of the current market size and future growth opportunities. This comprehensive study on the global Stem Cell Manufacturing market provides brief guidance to the market vendors, stakeholders, participants, and emerging players on dealing with the post-pandemic...